516 related articles for article (PubMed ID: 26150697)
21. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets.
Takabe K; Paugh SW; Milstien S; Spiegel S
Pharmacol Rev; 2008 Jun; 60(2):181-95. PubMed ID: 18552276
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer.
Ohotski J; Edwards J; Elsberger B; Watson C; Orange C; Mallon E; Pyne S; Pyne NJ
Int J Cancer; 2013 Feb; 132(3):605-16. PubMed ID: 22733311
[TBL] [Abstract][Full Text] [Related]
23. Dissecting the role of the S1P/S1PR axis in health and disease.
Aarthi JJ; Darendeliler MA; Pushparaj PN
J Dent Res; 2011 Jul; 90(7):841-54. PubMed ID: 21248363
[TBL] [Abstract][Full Text] [Related]
24. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy.
Ader I; Malavaud B; Cuvillier O
Cancer Res; 2009 May; 69(9):3723-6. PubMed ID: 19383898
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia, therapeutic resistance, and sphingosine 1-phosphate.
Cuvillier O; Ader I; Bouquerel P; Brizuela L; Gstalder C; Malavaud B
Adv Cancer Res; 2013; 117():117-41. PubMed ID: 23290779
[TBL] [Abstract][Full Text] [Related]
26. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis.
Karimian G; Buist-Homan M; Schmidt M; Tietge UJ; de Boer JF; Klappe K; Kok JW; Combettes L; Tordjmann T; Faber KN; Moshage H
Biochim Biophys Acta; 2013 Dec; 1832(12):1922-9. PubMed ID: 23816565
[TBL] [Abstract][Full Text] [Related]
27. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways.
Kim M; Kim M; Kim N; D'Agati VD; Emala CW; Lee HT
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1827-35. PubMed ID: 17898040
[TBL] [Abstract][Full Text] [Related]
28. High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients.
Watson C; Long JS; Orange C; Tannahill CL; Mallon E; McGlynn LM; Pyne S; Pyne NJ; Edwards J
Am J Pathol; 2010 Nov; 177(5):2205-15. PubMed ID: 20889557
[TBL] [Abstract][Full Text] [Related]
29. Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids.
Yan G; Chen S; You B; Sun J
Cardiovasc Res; 2008 May; 78(2):308-14. PubMed ID: 18192241
[TBL] [Abstract][Full Text] [Related]
30. Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo.
Roviezzo F; Brancaleone V; De Gruttola L; Vellecco V; Bucci M; D'Agostino B; Cooper D; Sorrentino R; Perretti M; Cirino G
J Pharmacol Exp Ther; 2011 Jun; 337(3):830-7. PubMed ID: 21421740
[TBL] [Abstract][Full Text] [Related]
31. Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.
Yaghobian D; Don AS; Yaghobian S; Chen X; Pollock CA; Saad S
Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):56-66. PubMed ID: 26414003
[TBL] [Abstract][Full Text] [Related]
32. A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma.
Salama MF; Carroll B; Adada M; Pulkoski-Gross M; Hannun YA; Obeid LM
FASEB J; 2015 Jul; 29(7):2803-13. PubMed ID: 25805832
[TBL] [Abstract][Full Text] [Related]
33. Elevated intrathymic sphingosine-1-phosphate promotes thymus involution during sepsis.
Kuchler L; Sha LK; Giegerich AK; Knape T; Angioni C; Ferreirós N; Schmidt MV; Weigert A; Brüne B; von Knethen A
Mol Immunol; 2017 Oct; 90():255-263. PubMed ID: 28846923
[TBL] [Abstract][Full Text] [Related]
34. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression.
Ishitsuka A; Fujine E; Mizutani Y; Tawada C; Kanoh H; Banno Y; Seishima M
Int J Mol Med; 2014 Oct; 34(4):1169-74. PubMed ID: 25109763
[TBL] [Abstract][Full Text] [Related]
35. Development of small-molecule inhibitors of sphingosine-1-phosphate signaling.
Edmonds Y; Milstien S; Spiegel S
Pharmacol Ther; 2011 Dec; 132(3):352-60. PubMed ID: 21906625
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the role of sphingosine 1-phosphate in cancer.
Pyne NJ; Pyne S
FEBS Lett; 2020 Nov; 594(22):3583-3601. PubMed ID: 32969034
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.
Sukocheva OA; Furuya H; Ng ML; Friedemann M; Menschikowski M; Tarasov VV; Chubarev VN; Klochkov SG; Neganova ME; Mangoni AA; Aliev G; Bishayee A
Pharmacol Ther; 2020 Mar; 207():107464. PubMed ID: 31863815
[TBL] [Abstract][Full Text] [Related]
38. Targeting sphingosine-1-phosphate receptors in cancer.
Watters RJ; Wang HG; Sung SS; Loughran TP; Liu X
Anticancer Agents Med Chem; 2011 Nov; 11(9):810-7. PubMed ID: 21707490
[TBL] [Abstract][Full Text] [Related]
39. Targeting sphingosine-1-phosphate signaling in lung diseases.
Ebenezer DL; Fu P; Natarajan V
Pharmacol Ther; 2016 Dec; 168():143-157. PubMed ID: 27621206
[TBL] [Abstract][Full Text] [Related]
40. Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth factor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion.
Adada MM; Canals D; Jeong N; Kelkar AD; Hernandez-Corbacho M; Pulkoski-Gross MJ; Donaldson JC; Hannun YA; Obeid LM
FASEB J; 2015 Nov; 29(11):4654-69. PubMed ID: 26209696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
